K-H Herbinger1, M Schunk, H D Nothdurft, F von Sonnenburg, T Löscher, G Bretzel. 1. Department of Infectious Diseases and Tropical Medicine, University Hospital, Ludwig-Maximilians University of Munich, Leopoldstraße 5, 80802 Munich, Germany. herbinger@lrz.uni-muenchen.de
Abstract
BACKGROUND: Thrombocytopenia is a frequent finding among ill returned travellers and may be caused by a large number of different conditions, including infectious diseases specific or typical for tropical and subtropical regions. In order to assess the diagnostic significance of thrombocytopenia we investigated a large cohort of returned travellers. METHODS: This was a comparative study in which data collected on 19,473 returned travellers who consulted the outpatient travel clinic of the the University of Munich Hospital between 1999 and 2009 were analysed. Of these, 732 (3.8%) travellers were diagnosed with thrombocytopenia, and their data were compared with those of the remaining 18,741 travellers with normal platelet counts. RESULTS: Thrombocytopenia was significantly more frequent among patients with malaria (63%), acute human immunodeficiency virus infection (48%), dengue fever/dengue haemorrhagic fever (DF/DHF; 47%), Epstein-Barr virus infectious mononucleosis (23%), paratyphoid/typhoid fever (14%), and rickettsiosis (12%). Malaria and DF/DHF caused 25% of all cases of thrombocytopenia (platelet count <140,000/μl) and 75% of all cases of severe thrombocytopenia (platelet count <30,000/μl). Sex, age, country of origin, duration and type of travel were not significantly correlated with thrombocytopenia. The most frequent travel destinations were Asia (42%), Africa (33%), and Latin America (14%). Travellers to Sub-Saharan Africa (high risk for malaria) and to South/South-east Asia (high risk for DF/DHF) had the highest relative risk for thrombocytopenia. CONCLUSION: Platelet count among returned travellers is an essential screening parameter, as thrombocytopenia is highly correlated with important infectious diseases, particularly with malaria and DF/DHF.
BACKGROUND:Thrombocytopenia is a frequent finding among ill returned travellers and may be caused by a large number of different conditions, including infectious diseases specific or typical for tropical and subtropical regions. In order to assess the diagnostic significance of thrombocytopenia we investigated a large cohort of returned travellers. METHODS: This was a comparative study in which data collected on 19,473 returned travellers who consulted the outpatient travel clinic of the the University of Munich Hospital between 1999 and 2009 were analysed. Of these, 732 (3.8%) travellers were diagnosed with thrombocytopenia, and their data were compared with those of the remaining 18,741 travellers with normal platelet counts. RESULTS:Thrombocytopenia was significantly more frequent among patients with malaria (63%), acute human immunodeficiency virus infection (48%), dengue fever/dengue haemorrhagic fever (DF/DHF; 47%), Epstein-Barr virus infectious mononucleosis (23%), paratyphoid/typhoid fever (14%), and rickettsiosis (12%). Malaria and DF/DHF caused 25% of all cases of thrombocytopenia (platelet count <140,000/μl) and 75% of all cases of severe thrombocytopenia (platelet count <30,000/μl). Sex, age, country of origin, duration and type of travel were not significantly correlated with thrombocytopenia. The most frequent travel destinations were Asia (42%), Africa (33%), and Latin America (14%). Travellers to Sub-Saharan Africa (high risk for malaria) and to South/South-east Asia (high risk for DF/DHF) had the highest relative risk for thrombocytopenia. CONCLUSION: Platelet count among returned travellers is an essential screening parameter, as thrombocytopenia is highly correlated with important infectious diseases, particularly with malaria and DF/DHF.
Authors: Felipe Francisco Tuon; Hermes Ryoiti Higashino; Valdir Sabbaga Amato; Antonio Carlos Nicodemo Journal: Int J Infect Dis Date: 2008-03-26 Impact factor: 3.623
Authors: Qurban Hussain Shaikh; Syed Masroor Ahmad; Amanullah Abbasi; Shujaat Ali Malik; Abdul Aziz Sahito; S M Munir Journal: J Coll Physicians Surg Pak Date: 2009-11 Impact factor: 0.711
Authors: J F P Wagenaar; M G A Goris; D L Partiningrum; B Isbandrio; R A Hartskeerl; D P M Brandjes; J C M Meijers; M H Gasem; E C M van Gorp Journal: Trop Med Int Health Date: 2009-12-09 Impact factor: 2.622
Authors: Kishore R Alugupalli; Alan D Michelson; Isabelle Joris; Tom G Schwan; Kairbaan Hodivala-Dilke; Richard O Hynes; John M Leong Journal: Blood Date: 2003-07-10 Impact factor: 22.113
Authors: K-H Herbinger; M Metzner; V Schmidt; M Beissner; H D Nothdurft; F von Sonnenburg; T Löscher Journal: Infection Date: 2013-09-08 Impact factor: 3.553
Authors: Karl-Heinz Herbinger; Martin Alberer; Nicole Berens-Riha; Mirjam Schunk; Gisela Bretzel; Frank von Sonnenburg; Hans Dieter Nothdurft; Thomas Löscher; Marcus Beissner Journal: Am J Trop Med Hyg Date: 2016-02-22 Impact factor: 2.345
Authors: Karl-Heinz Herbinger; Ingrid Hanus; Mirjam Schunk; Marcus Beissner; Frank von Sonnenburg; Thomas Löscher; Gisela Bretzel; Michael Hoelscher; Hans Dieter Nothdurft; Kristina Lydia Huber Journal: Am J Trop Med Hyg Date: 2016-08-15 Impact factor: 2.345
Authors: Nicole Berens-Riha; Inge Kroidl; Mirjam Schunk; Martin Alberer; Marcus Beissner; Michael Pritsch; Arne Kroidl; Günter Fröschl; Ingrid Hanus; Gisela Bretzel; Frank von Sonnenburg; Hans Dieter Nothdurft; Thomas Löscher; Karl-Heinz Herbinger Journal: Malar J Date: 2014-04-23 Impact factor: 2.979